Cheryl Zimberlin, PhD, joined Merck Ventures in May 2016 and is currently an Associate in the Healthcare team. Cheryl received her BSc. Hons. in Biology from the University of Utrecht, a MSc in Biotechnology from the University of Wageningen and a PhD in Oncology from the University of Amsterdam. Before joining Merck Ventures she had a successful academic career publishing in top-tier academic journals, including Nature. Cheryl is based in Amsterdam and is board observer in Inthera Bioscience.